Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2013-10-31
2022-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Up to 300 patients diagnosed with abdominal aortic aneurysm (AAA) who are considered candidates for Endovascular Repair, in up to 30 international centers will be enrolled in the study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nellix Registry Study: EVAS-Global
NCT02996396
The Nellix® EndoVascular Aneurysm Sealing System for the Treatment of Infrarenal Abdominal Aortic Aneurysms
NCT02048514
EVAS2 IDE Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study
NCT03298477
Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System
NCT01726257
Dynamic CT Imaging After Nellix Endoprosthesis Implantation
NCT02438605
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2. Procedure: implantation information
3. Discharge: Physical exam, bloodwork and adverse events, if any
4. Follow-up according to institutional standard through to 5 years including Physical exam, CT image or standard of care imaging eg Doppler Ultrasound, bloodwork and adverse events, if any
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Subject has signed informed consent for data release
3. Subjects with AAA and eligible for endovascular repair
Exclusion Criteria
2. Known allergy to any of the device components
3. Pregnant (females of childbearing potential only)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Endologix
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Prof Andrew Holden
Role: PRINCIPAL_INVESTIGATOR
Auckland City Hospital
Dr. Michel Reijnen, MD
Role: PRINCIPAL_INVESTIGATOR
Rijnstate Hospital, Arnhem NL
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Klinikum Augsburg Klinik für Gefäßchirurgie
Augsburg, , Germany
Universitätsklinikum Düsseldorf Klinik für Gefäß- und Endovaskularchirurgie
Düsseldorf, , Germany
Alfried Krupp Krankenhaus Ruttenscheid, Vascular Centre
Essen, , Germany
Universitätsklinikum Heidelberg Klinik für Gefäßchirurgie Im Neuenheimer Feld
Heidelberg, , Germany
Klinikum Sud Nuernberg, Dept of Vascular Surgery
Nuremberg, , Germany
Klinikum Stuttgart Katharinenen Hospital
Stuttgart, , Germany
Pauls Stadins Clinical University Hospital Riga
Riga, , Latvia
Hopital Kirchberg, Dept of Cardio-Vascular
Luxembourg-Kirchberg, , Luxembourg
Academisch Medisch Centrum Amsterdam, Department of Surgery
Amsterdam, , Netherlands
Rijnstate Ziekenhuis, Vasculaire Centrum
Arnhem, , Netherlands
St Antonius Ziekenhuis, Dept of Vascular Surgery
Nieuwegein, , Netherlands
Erasmus Medical Centre, Dept of Vascular Surgery
Rotterdam, , Netherlands
St Elisabeth Ziekenhuis, Dept of Vascular Surgery
Tilburg, , Netherlands
Auckland City Hospital Interventional Radiology
Auckland, , New Zealand
Hospital Hamar
Hamar, , Norway
Orebro University Hospital, Department of General Surgery
Örebro, , Sweden
Karolinska University Hospital
Stockholm, , Sweden
Addenbrooke's Hospital, Dept of Vascular Surgery
Cambridge, , United Kingdom
St. George's Vascular Institute
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CP0010-Ver. 1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.